A Preliminary Investigation of Ibogaine: Case Reports and Recommendations for Further Study
Outcomes Case series landmark
AI-extracted · unverified · confirm at source
First published case series (N=7): ibogaine 700–1800 mg (11.7–25 mg/kg) abolished opiate withdrawal in all subjects; 3/7 remained drug-free ≥14 weeks; higher doses correlated with better outcomes.
Dosing: 700–1,800 mg ibogaine hydrochloride (11.7–25 mg/kg); 100–200 mg trial dose followed by remainder (oral)
Sample size: 7